SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression

Proposed model of SALL4’s role in gastric cancer angiogenesis. SALL4 functions as a transcription factor that binds to VEGF-A, B, and C promoters and activates their expression. Exosomal delivery of si-SALL4-B and thalidomide results in targeted inhibition of SALL4-B and VEGF-A, B, and C expression, leading to suppression of gastric cancer angiogenesis
SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression

Publication

SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression. (2023) Fatma A. Abouelnazar, et al. Cancer Cell Int. 2023;23:149. Figure: F9.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates VEGF-A,B,C VEGFC ncbigene_symbol VEGFC 7424
Homo sapiens Primates VEGF-A,B,C VEGFA ncbigene_symbol VEGFA 7422
Homo sapiens Primates VEGF-A,B,C VEGFB ncbigene_symbol VEGFB 7423

Chemical mentions

Word Match MeSH Name ChEBI
Thalidomide Thalidomide mesh:D013792 thalidomide chebi:9513

Disease mentions

Word Match MeSH Name DOID
Cancer NA mesh:D009369